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GII.6, GI.3/GII.17, GI.7/GII.17, and GI.7/GII.P7-GII.6). We 
did not perform dual typing on GI strains because they were 
less predominant than GII strains. However, future analysis 
of their recombination patterns will be useful for better char-
acterizing these rare but potentially significant genotypes. 
This study was somewhat limited by lack of detailed clinical 
information accompanying the submitted samples and ab-
sence of surveillance from southern Thailand (≈14% of the 
country’s population). Molecular epidemiology and contin-
ued surveillance of norovirus strain diversity will increase 
awareness among clinicians and help epidemiologists deter-
mine global transmission patterns.
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We report a case of Sneathia amnii as the causative agent 
of maternal chorioamnionitis and congenital pneumonia 
resulting in a late fetal death in Mozambique, with strong 
supportive postmortem molecular and histopathologic con-
firmation. This rare, fastidious gram-negative coccobacillus 
has been reported to infrequently cause abortions, still-
births, and neonatal infections.
Sneathia amnii, formerly designated Leptotrichia amnion-ii, is a rare, fastidious, gram-negative coccobacillus, first 
described in the amniotic fluid of a woman with a fetal de-
mise (1). The inherent difficulties in conventionally culturing 
this pathogen led to its initial identification through analyz-
ing the 16S rRNA gene; its genome was recently sequenced 
(1,2). S. amnii is an opportunistic agent of the female urogen-
ital tract (3,4) associated with cases of spontaneous abortion 
(miscarriage) and neonatal meningitis (1,5,6). We describe a 
perinatal case of S. amnii infection in a mother–fetus dyad, 
which we documented and investigated with the minimally 
invasive tissue sampling (MITS) postmortem procedure (7).
An otherwise healthy multigravida 37-year-old woman, 
at an estimated gestational age of 39 weeks, was admitted to 
Manhiça District Hospital, southern Mozambique, in labor. 
During pregnancy, she had attended 2 antenatal consulta-
tions and received the standard of care for pregnant women 
in Mozambique; mild anemia was treated with ferrous sul-
fate and folic acid supplements. Serologic tests for syphilis 
and HIV were both negative. Upon arrival at the hospital, the 
mother was afebrile and hemodynamically stable; she had a 
fully effaced uterine cervix, thin and elastic, 2 cm dilation; 
intact amniotic membranes; and cephalic fetal presentation 
with heartbeat present. Physical examination did not provide 
additional information. Labor progressed with spontaneous 
rupture of membranes. No additional documentation of the 
fetal heartbeat was available before delivery. Two hours after 
arrival, a fresh stillborn female weighing 3.5 kg was born 
by spontaneous vaginal delivery. Size was normal, and no 
macroscopic congenital abnormalities were observed. The 
mother was discharged next day without complications.
As part of Mozambique’s Child Health and Mortal-
ity Prevention Surveillance (CHAMPS), after obtaining 
written, informed consent, we conducted MITS by biopsy 
needle of tissues and body fluids, in addition to placenta, to 
ascertain the cause of the stillbirth (7). Samples are subject 
to thorough histopathologic, molecular, and microbiologi-
cal investigation, including universal screening for HIV-1, 
Mycobacterium tuberculosis, and malaria parasites. We 
performed conventional microbiological cultures of blood 
and cerebrospinal fluid (CSF); we inoculated ≈3 mL of 
blood into aerobic blood culture bottle (BACTEC system; 
Becton Dickinson, https://www.bd.com) and cultured CSF 
samples into blood, chocolate, and MacConkey agar plates. 
We performed multipathogen molecular screening using 
TaqMan Array Card (Applied Biosystems, https://www.
thermofisher.com) in whole blood, CSF, lung, and rectal 
swab samples (8). We prepared and examined tissue sam-
ples using conventional pathologic methods and targeted 
immunohistochemical staining (9).
We isolated no microorganisms in CSF or blood, 
nor did we detect a likely pathogen in any of the unfixed 
Figure. Histologic evidence 
of amniotic fluid aspiration, 
bronchopneumonia, and 
intraalveolar gram-negative 
coccobacilli in the lung of a 
stillborn infant, Mozambique. A) 
Hematoxylin and eosin stain of lung 
tissue showing acute inflammation 
within alveoli (bronchopneumonia, 
upper arrow) and moderate 
numbers of aspirated squames 
(lower arrow), consistent with 
intrauterine fetal distress and 
associated aspiration of amniotic 
fluid. Original magnification ×20. 
B) Higher magnification of panel A 
tissue showing acute inflammation 
within alveoli (bronchopneumonia) 
and a clump of aspirated squames. 
Original magnification ×40. C) 
Gram stain of lung showing 
multiple small, gram-negative 
coccobacilli mixed with acute 
inflammation within alveoli (arrows 
indicate regions with bacteria). 
Original magnification ×63. D) Polybacterial immunohistochemical assay of lung tissue targeting multiple bacteria highlights the coccobacilli 
within alveoli (top and bottom arrows). Aspirated squames are also present (middle arrow). Original magnification ×63.
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postmortem tissues. At CHAMPS reference pathology labo-
ratories, examination of tissue samples showed similar mor-
phological findings in placental and miscellaneous tissues 
that suggested infection, including an acute inflammatory 
infiltrate in the lungs compatible with bronchopneumonia. 
We also found moderate numbers of aspirated squames and 
increased alveolar macrophages, indicating intrauterine fetal 
distress and associated aspiration of amniotic fluid. No aspi-
rated meconium was apparent. Gram stain revealed gram-
negative coccobacilli in alveoli and adjacent bronchioles. 
We conducted a cross-reactive immunohistochemical assay 
targeting multiple bacteria in the lung samples using paneu-
bacteria and gram type–specific PCR assays targeting the 
16S rRNA gene; we identified S. amnii by sequence analysis 
of positive amplicons (Figure, panels A–C). We observed no 
remarkable histopathologic findings in the liver or brain, and 
the cross-reactive polybacterial immunohistochemical assay 
was negative in brain tissue. Placental tissue and umbilical 
cord showed an acute chorioamnionitis with maternal re-
sponse (inflammation in the membranes, stage 2) and fetal 
response (inflammation in the umbilical cord, stage 2) show-
ing umbilical arteritis with rare gram-negative coccobacilli. 
There was no immunohistochemical evidence of bacteria 
in this tissue (Figure 1, panel D). We obtained an amplicon 
from placental tissue by paneubacteria PCR; however, we 
could not confirm the presence of S. amnii sequences. 
CHAMPS procedures include the review of all clini-
cal, microbiological, molecular, and histopathological 
data, along with the verbal autopsy, by a multidisciplinary 
panel of local experts (D.M. Blau et al., unpub. data). The 
panel concluded that the immediate cause of this stillbirth 
could be attributed to a congenital pneumonia, caused 
by S. amnii, that could have originated in the mother’s 
placenta; we determined that chorioamnionitis was the 
main maternal condition associated with the child’s death. 
The presence of Sneathia sp. bacteria in amniotic fluid 
can lead to inflammation and histologic chorioamnionitis, 
amnionitis, or both (10). 
S. amnii has been identified in different settings as a 
pathologic agent in women and children (1,3–6). In this 
case in a rural setting in Africa, S. amnii was the causative 
agent in a stillbirth with congenital pneumonia, a diagnosis 
supported by strong postmortem molecular and histopatho-
logic confirmation. As CHAMPS evaluation continues in 
Mozambique, as well as at sites in 6 additional countries in 
sub-Saharan Africa and south Asia, we expect the impor-
tance of this pathogen to become clearer.
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